SCHEMBL6002859

SCHEMBL6002859

Cc1ccc(C(CO)c2ccc(C)c(C)c2)cc1C

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.39
PTGS1 P23219 1/20 0.39
CACNA1C Q13936 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
ALDH1A1 P00352 4/20 0.36
MCL1 Q07820 1/20 0.36
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
TP53 P04637 1/20 0.35
PRSS1 P07477 1/20 0.34
PRSS2 P07478 1/20 0.34
PRSS3 P35030 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17086648 0.80 ABCB11 (0.50) TRPA1PTGS1CACNA1CTDP1ALDH1A1
SCHEMBL28704040 0.80 CYP3A4 (0.50) TRPA1PTGS1CACNA1CSMN1; SMN2TDP1
SCHEMBL11705337 0.79 SMN1; SMN2 (0.43) TRPA1PTGS1CACNA1CSMN1; SMN2TDP1
SCHEMBL3636225 0.78 ALDH1A1 (0.38) TRPA1PTGS1CACNA1CSMN1; SMN2ALDH1A1
SCHEMBL11705367 0.76 TAS1R3 (0.40) TRPA1PTGS1CACNA1CSMN1; SMN2TDP1
SCHEMBL9570752 0.74 ESR1 (0.37) TRPA1PTGS1CACNA1CSMN1; SMN2ALDH1A1
SCHEMBL14182599 0.73 TRPA1 (0.43) TRPA1PTGS1CACNA1CSMN1; SMN2TDP1
SCHEMBL822085 0.73 TRPA1 (0.43) TRPA1PTGS1CACNA1CTDP1ALDH1A1
SCHEMBL29403039 0.73 TRPA1 (0.43) TRPA1PTGS1CACNA1CTDP1ALDH1A1
SCHEMBL5307487 0.73 POLB (0.41) SMN1; SMN2TDP1ALDH1A1POLBNR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed